Fosphenytoin Sodium Patent Expiration

Fosphenytoin Sodium was first introduced by Parke Davis Div Warner Lambert Co in its drug Cerebyx on Aug 5, 1996. Another drug containing Fosphenytoin Sodium is Sesquient. 14 different companies have introduced drugs containing Fosphenytoin Sodium.


Fosphenytoin Sodium Patents

Given below is the list of patents protecting Fosphenytoin Sodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sesquient US9493582 Alkylated cyclodextrin compositions and processes for preparing and using the same Feb 27, 2033 Lupin
Sesquient US7635773 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Lupin
Sesquient US8410077 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Lupin
Sesquient US9200088 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Lupin
Sesquient US9750822 Sulfoalkyl ether cyclodextrin compositions Mar 13, 2029 Lupin



Fosphenytoin Sodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fosphenytoin Sodium Generic API Manufacturers

Several generic applications have been filed for Fosphenytoin Sodium. The first generic version for Fosphenytoin Sodium was by Dr Reddys Laboratories Ltd and was approved on Aug 6, 2007. And the latest generic version is by Gland Pharma Ltd and was approved on Oct 13, 2023.

Given below is the list of companies who have filed for Fosphenytoin Sodium generic, along with the locations of their manufacturing plants worldwide.